The largest family of specialized venture capital funds that invests exclusively in companies developing novel therapeutics for dementia
Number of Investments: 40
Number of Exits: 3
Investment Industries: Biotechnology;Life Science;Neuroscience;Venture Capital
Investment Categories: Early Stage Venture;Seed;Venture
Email: ddf2deals@svhealthinvestors.com
Location: London, England, United Kingdom